Protara Therapeutics (TARA) Interest & Investment Income (2013 - 2026)
Protara Therapeutics' (TARA) quarterly Interest & Investment Income came in at -$454000.0 in Q1 2026, down 621.84% year-on-year from $87000.0 in Q1 2025, and down 756.6% on a QoQ basis from -$53000.0 in Q4 2025.
Protara Therapeutics (TARA) Interest & Investment Income (2013 - 2026) Analysis & Trends
Protara Therapeutics (TARA) has 13 years of Interest & Investment Income data on file, last reported at -$454000.0 in Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 621.84% year-over-year to -$454000.0 in Q1 2026; TTM through Mar 2026 was -$82000.0, a 101.81% decrease from a year earlier, with the FY2025 full-year figure at $88000.0, down 97.35% from the prior year.
- Interest & Investment Income for Q1 2026 stood at -$454000.0, down from -$53000.0 in the prior quarter.
- Over the last five years, Interest & Investment Income for TARA reached as high as $3.3 million in Q4 2024 and fell as low as -$1.7 million in Q4 2023.
- Historically, Interest & Investment Income has averaged $200058.8 across 5 years, with a median of $68000.0 in 2024.
- Across the five-year window, Interest & Investment Income tumbled 687.16% in 2023 and soared 1406.9% in 2025, its largest moves.
- Year by year, Interest & Investment Income stood at -$218000.0 in 2022, then tumbled by 687.16% to -$1.7 million in 2023, then jumped by 290.33% to $3.3 million in 2024, then tumbled by 101.62% to -$53000.0 in 2025, then plunged by 756.6% to -$454000.0 in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were -$454000.0 in Q1 2026, -$53000.0 in Q4 2025, and $437000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Protara Therapeutics | 232.74 Mn | 232.74 Mn | - | -454,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -454,000.00 |
| Dec 31, 2025 | -53,000.00 |
| Sep 30, 2025 | 437,000.00 |
| Jun 30, 2025 | -12,000.00 |
| Mar 31, 2025 | 87,000.00 |
| Dec 31, 2024 | 3.27 Mn |
| Sep 30, 2024 | 29,000.00 |
| Jun 30, 2024 | 1.15 Mn |
| Mar 31, 2024 | 68,000.00 |
| Dec 31, 2023 | -1.72 Mn |
| Sep 30, 2023 | 710,000.00 |
| Jun 30, 2023 | 132,000.00 |
| Mar 31, 2023 | 605,000.00 |
| Dec 31, 2022 | -218,000.00 |
| Sep 30, 2022 | 283,000.00 |
| Jun 30, 2022 | -180,000.00 |
| Mar 31, 2022 | -731,000.00 |
| Dec 31, 2021 | 276,000.00 |
| Sep 30, 2021 | 53,000.00 |
| Jun 30, 2021 | 63,000.00 |